328 related articles for article (PubMed ID: 16497969)
1. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
Rosenberg PS; Alter BP; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Fier C; Freedman M; Kannourakis G; Kinsey S; Schwinzer B; Zeidler C; Welte K; Dale DC;
Blood; 2006 Jun; 107(12):4628-35. PubMed ID: 16497969
[TBL] [Abstract][Full Text] [Related]
2. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.
Rosenberg PS; Zeidler C; Bolyard AA; Alter BP; Bonilla MA; Boxer LA; Dror Y; Kinsey S; Link DC; Newburger PE; Shimamura A; Welte K; Dale DC
Br J Haematol; 2010 Jul; 150(2):196-9. PubMed ID: 20456363
[TBL] [Abstract][Full Text] [Related]
3. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.
Freedman MH; Alter BP
Semin Hematol; 2002 Apr; 39(2):128-33. PubMed ID: 11957196
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
Freedman MH; Bonilla MA; Fier C; Bolyard AA; Scarlata D; Boxer LA; Brown S; Cham B; Kannourakis G; Kinsey SE; Mori PG; Cottle T; Welte K; Dale DC
Blood; 2000 Jul; 96(2):429-36. PubMed ID: 10887102
[TBL] [Abstract][Full Text] [Related]
5. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
6. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
Donadieu J; Leblanc T; Bader Meunier B; Barkaoui M; Fenneteau O; Bertrand Y; Maier-Redelsperger M; Micheau M; Stephan JL; Phillipe N; Bordigoni P; Babin-Boilletot A; Bensaid P; Manel AM; Vilmer E; Thuret I; Blanche S; Gluckman E; Fischer A; Mechinaud F; Joly B; Lamy T; Hermine O; Cassinat B; Bellanné-Chantelot C; Chomienne C;
Haematologica; 2005 Jan; 90(1):45-53. PubMed ID: 15642668
[TBL] [Abstract][Full Text] [Related]
7. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
[TBL] [Abstract][Full Text] [Related]
8. Prevention and control of infections in patients with severe congenital neutropenia; a follow up study.
Salehi T; Fazlollahi MR; Maddah M; Nayebpour M; Tabatabaei Yazdi M; Alizadeh Z; Eshghi P; Chavoshzadeh Z; Movahedi M; Hamidieh AA; Cheraghi T; Pourpak Z; Moin M
Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):51-6. PubMed ID: 22427476
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
10. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis.
Grigull L; Pulver N; Goudeva L; Sykora KW; Linderkamp C; Beilken A; Seidemann K; Schmid H; Welte K; Heuft HG
Support Care Cancer; 2006 Sep; 14(9):910-6. PubMed ID: 16622651
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of induction chemotherapy for patients with high-risk myelodysplastic syndrome (MDS) or MDS-transformed acute myeloid leukemia with CHG regimen and its comparison with regimen GAG and HA].
Su JY; Chang CK; Zhang X; Zhou LY; Song LQ; Xu L; Wu LY; He Q; Li X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):459-63. PubMed ID: 19379588
[TBL] [Abstract][Full Text] [Related]
12. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.
Dale DC; Bolyard AA; Marrero T; Kelley ML; Makaryan V; Tran E; Leung J; Boxer LA; Kishnani PS; Austin S; Wanner C; Ferrecchia IA; Khalaf D; Maze D; Kurtzberg J; Zeidler C; Welte K; Weinstein DA
Curr Opin Hematol; 2019 Jan; 26(1):16-21. PubMed ID: 30451720
[TBL] [Abstract][Full Text] [Related]
13. Detection of myelodysplastic syndrome/ acute myeloid leukemia evolving from aplastic anemia in children, treated with recombinant human G-CSF.
Imashuku S; Hibi S; Bessho F; Tsuchida M; Nakahata T; Miyazaki S; Tsukimoto I; Hamajima N;
Haematologica; 2003 Nov; 88(11):ECR31. PubMed ID: 14607763
[TBL] [Abstract][Full Text] [Related]
14. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
Choi SW; Boxer LA; Pulsipher MA; Roulston D; Hutchinson RJ; Yanik GA; Cooke KR; Ferrara JL; Levine JE
Bone Marrow Transplant; 2005 Mar; 35(5):473-7. PubMed ID: 15640815
[TBL] [Abstract][Full Text] [Related]
15. [Gene Mutation and Acute Leukemia Transformation of Severe Congenital Neutropenia- Review].
Chi ZH; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1580-1584. PubMed ID: 29070147
[TBL] [Abstract][Full Text] [Related]
16. Absence of mutations in the granulocyte colony-stimulating factor (G-CSF) receptor gene in patients with myelodysplastic syndrome/acute myeloblastic leukaemia occurring after treatment of aplastic anaemia with G-CSF.
Kudo K; Nagai H; Numata S; Ichihara M; Kinoshita T; Horibe K; Kato K; Matsuyama T; Kodera Y; Kojima S
Br J Haematol; 2000 Nov; 111(2):656-8. PubMed ID: 11122117
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia.
Jeha S; Chan KW; Aprikyan AG; Hoots WK; Culbert S; Zietz H; Dale DC; Albitar M
Blood; 2000 Nov; 96(10):3647-9. PubMed ID: 11071667
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of leukemic transformation in congenital neutropenia.
Link DC
Curr Opin Hematol; 2019 Jan; 26(1):34-40. PubMed ID: 30431463
[TBL] [Abstract][Full Text] [Related]
19. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
[TBL] [Abstract][Full Text] [Related]
20. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]